Simultaneous development of Graves’ disease and type 1 diabetes during anti‐programmed cell death‐1 therapy: A case report

We present the first case of simultaneous development of Graves’ disease and type 1 diabetes during anti‐programmed cell death 1 therapy. A 48‐year‐old man with parotid gland adenocarcinoma and lung metastasis had received five courses of nivolumab. Fourteen days after administration of the sixth co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurihara, Susumu, Oikawa, Yoichi, Nakajima, Ritsuko, Satomura, Atsushi, Tanaka, Ryuhei, Kagamu, Hiroshi, Shimada, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378416/
https://www.ncbi.nlm.nih.gov/pubmed/31926048
http://dx.doi.org/10.1111/jdi.13212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378416/
https://www.ncbi.nlm.nih.gov/pubmed/31926048
http://dx.doi.org/10.1111/jdi.13212

Ejemplares similares